4//SEC Filing
Kung Winston 4
Accession 0000950170-25-080313
CIK 0001595097other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:30 PM ET
Size
7.3 KB
Accession
0000950170-25-080313
Insider Transaction Report
Form 4
Kung Winston
Director
Transactions
- Award
Stock options (right to buy)
2025-05-30+16,000→ 16,000 totalExercise: $7.42Exp: 2035-05-30→ Common Stock (16,000 underlying) - Award
Common Stock, par value $0.0001 per share
2025-05-30+4,800→ 10,366 total
Footnotes (3)
- [F1]On May 30, 2025, 4,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.
- [F2]This amount includes 10,366 unvested RSUs subject to each grant's vesting schedule as previously reported.
- [F3]The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001666963
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:30 PM ET
- Size
- 7.3 KB